Menu
GWAS Study

Multi-trait genetic analysis identifies auto-immune loci associated with cutaneous melanoma.

Liyanage UE, MacGregor S, Bishop DT et al.

34813871 PubMed ID
GWAS Study Type
2012989 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

LU
Liyanage UE
MS
MacGregor S
BD
Bishop DT
SJ
Shi J
AJ
An J
OJ
Ong JS
HX
Han X
SR
Scolyer RA
MN
Martin NG
MS
Medland SE
BE
Byrne EM
GA
Green AC
SR
Saw RPM
TJ
Thompson JF
SJ
Stretch J
SA
Spillane A
JY
Jiang Y
TC
Tian C
GS
Gordon SG
DD
Duffy DL
OC
Olsen CM
WD
Whiteman DC
LG
Long GV
IM
Iles MM
LM
Landi MT
LM
Law MH
Chapter II

Abstract

Summary of the research findings

Genome-wide association studies (GWAS) have identified a number of risk loci for cutaneous melanoma. Cutaneous melanoma shares overlapping genetic risk (genetic correlation) with a number of other traits, including its risk factors such as sunburn propensity. This genetic correlation can be exploited to identify additional cutaneous melanoma risk loci by multitrait analysis of GWAS (MTAG). We used bivariate linkage disequilibrium-score regression score regression to identify traits that are genetically correlated with clinically confirmed cutaneous melanoma and then used publicly available GWAS for these traits in a multitrait analysis of GWAS. Multitrait analysis of GWAS allows GWAS to be combined while accounting for sample overlap and incomplete genetic correlation. We identified a total of 74 genome-wide independent loci, 19 of them were not previously reported in the input cutaneous melanoma GWAS meta-analysis. Of these loci, 55 were replicated (P < 0.05/74, Bonferroni-corrected P-value in two independent cutaneous melanoma replication cohorts from Melanoma Institute Australia and 23andMe, Inc. Among the, to our knowledge, previously unreported cutaneous melanoma loci are ones that have also been associated with autoimmune traits including rs715199 near LPP and rs10858023 near AP4B1. Our analysis indicates genetic correlation between traits can be leveraged to identify new risk genes for cutaneous melanoma.

380,287 European ancestry individuals

Chapter III

Study Statistics

Key metrics and study information

2012989
Total Participants
GWAS
Study Type
Yes
Replicated
4,089 European ancestry cases, 11,901 European ancestry controls, 44,848 cases, 1,571,864 controls
Replication Participants
European
Ancestry
Greece, U.S., Italy, U.K., Australia, France, Germany, Spain
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.